Clinical Trials Directory

Trials / Unknown

UnknownNCT00349505

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
67 (planned)
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated by surgery and a total of 6 cycles of platinum based chemotherapy. A second look operation is performed after treatment; during this second look secondary cytoreductive surgery is accepted without bowel resection.If none or milimetric peritoneal disease is obseved an intraperitoneal chemotherapy is achieve

Conditions

Interventions

TypeNameDescription
PROCEDUREhyper thermic chemo + surgery

Timeline

Start date
2004-09-01
First posted
2006-07-07
Last updated
2006-10-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00349505. Inclusion in this directory is not an endorsement.

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma (NCT00349505) · Clinical Trials Directory